Baxter Nicholas W 4
4 · Lexaria Bioscience Corp. · Filed Oct 13, 2022
Insider Transaction Report
Form 4
Baxter Nicholas W
Director
Transactions
- Award
Stock Options
2022-10-12+18,200→ 30,000 totalExercise: $1.96From: 2022-10-12Exp: 2027-10-12→ Common Shares (18,200 underlying)
Holdings
- 1,500
Stock Options
Exercise: $5.31From: 2021-04-26Exp: 2026-04-26→ Common Shares (1,500 underlying) - 6,500
Stock Options
Exercise: $7.08From: 2021-06-08Exp: 2026-06-08→ Common Shares (5,000 underlying) - 11,000
common shares
- 8,400
Stock Options
Exercise: $6.23From: 2021-09-01Exp: 2026-09-01→ Common Shares (1,900 underlying) - 11,800
Stock Options
Exercise: $3.39From: 2022-03-08Exp: 2027-03-08→ Common Shares (3,400 underlying)